CROVALIMAB

UNII:	H9KH1GP3UU
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	CROVALIMAB
GSRS Full Record:	H9KH1GP3UU i

1917321-26-6
COMPLEMENT C5 INHIBITORY HUMANIZED RECYCLING MONOCLONAL ANTIBODY (RG-6107 )
CROVALIMAB [USAN]
Crovalimab
Crovalimab [JAN]
Crovalimab [WHO-DD]
Crovalimab akkz [WHO-DD]
Crovalimab-AKKZ
Immunoglobulin G1, anti-(human complement C5)(humanized RO7112689 heavy chain), disulfide with humanized RO7112689 light chain, dimer
Immunoglobulin G1-kappa, anti-[Homo sapiens C5 (complement 5)], monoclonal antibody; gamma1 heavy chain (1-451) [VH (Vicugna pacos IGHV3S1*01 (70.4%)/Homo sapiens IGHV3-66*01 (69.4%) -(IGHD)-Homo sapiens IGHJ4*01 (100%)) [9.8.15] (1-123) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 (CH1 R120>K (220) (124-221), hinge (222-236), CH2 L1.2>R (241), G1.1>R (242), S3>K (245), A110>G (333), A115>S (336), P116>S (337) (237-346), CH3 E12 (362), M14 (364), M107>L (434), N114>A (440), Q118>R (444), S120>E (446) (347-451), CHS G1>del, K2>del) (124-451)], (226-217')-disulfide with kappa light chain (1'-217') [VKAPPA (Homo sapiens IGKV1-13*02 or IGKV1D-13*01 (94.3%) -IGKJ4*01 (100%)) [6.3.12] (1'-110') -Homo sapiens IGKC*01, Km3 A45.1 (156), V101 (194) (111'- 217')]; dimer (232-232":235-235")-bisdisulfide
PIASKY
RG-6107
RG6107
RO-7112689
RO7112689
SKY-59
SKY59
crovalimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CROVALIMAB

Synonyms and Mappings

Resources